Skip to Content

Chemophase FDA Approval Status

FDA Approved: No
Brand name: Chemophase
Generic name: recombinant human hyaluronidase
Company: Halozyme Therapeutics, Inc.
Treatment for: Chemoadjuvant

Chemophase is a novel recombinant investigational therapeutic being developed to enhance the delivery of chemotherapy.

Development Timeline for Chemophase

DateArticle
Jun 30, 2005Halozyme Therapeutics Announces Submission of Investigational New Drug Application

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.